Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000394110 | SCV000343579 | uncertain significance | not provided | 2016-07-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083609 | SCV000630848 | likely benign | Walker-Warburg congenital muscular dystrophy | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000394110 | SCV000981983 | likely benign | not provided | 2020-06-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446530 | SCV002682760 | likely benign | Cardiovascular phenotype | 2019-05-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001275317 | SCV001460342 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2019-12-24 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001729511 | SCV001978775 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000394110 | SCV001979983 | likely benign | not provided | no assertion criteria provided | clinical testing |